Patent Assignment
Reel/Frame 023870/0001
Change of Name
Recorded: 2010-01-29
Pages: 23
Assignor
MERCK & CO., INC.
Executed: 2009-11-02
Assignee
MERCK SHARP & DOHME CORP.
126 EAST LINCOLN AVENUE, RAHWAY, NEW JERSEY, 07065
Covered Properties
(142)
Novel Hmg-Coa Reductase Inhibitors
Patent:
36,481 →
Application:
09/188,158 →
4-Azasteroids for Treatment of Hyperandrogenic Conditions
Patent:
39,056 →
Application:
10/020,740 →
Heterocyclic Cyclopentyl Tetrahydroisoquinoline and Tetrahydropyridopyridine Modulators of Chemokine Receptor Activity
Antifungal Combination Therapy
Patent:
38,984 →
Application:
10/325,137 →
Hepatitis C Virus Vaccine
Heteroaryl Substituted Pyrazole Modulators of Metabotropic Glutamate Receptor-5
Edg Receptor Agonists
17-Hydroxy 4-Aza Androstan -3-Ones as Androgen Receptor Modulators
Di-Aryl Substituted Tetrazole Modulators of Metabotropic Glutamate Receptor-5
Compounds Useful in the Treatment of Anthrax and Inhibiting Lethal Factor
Aminoalkylphenols, Methods of Using and Making the Same
Treatment of Neuropathic Pain with 6H-Pyrrolo[3,4-D]Pyridazine Compounds
Ppar Alpha Selective Compounds for the Treatment of Dyslipidemia and Other Lipid Disorders
Tyrosine Kinase Inhibitors
Dihydroxypyridopyrazine-1,6-Dione Compounds Useful as Hiv Integrase Inhibitors
Removal of Aldehyde Impurity by Reactive Polystyrene Resini
Heterarylpiperidine Modulators of Chemokine Receptor Activity
Ophthalmic Compositions for Treating Ocular Hypertension
Carbonylamino-Benzimidazole Derivatives as Androgen Receptor Modulators
Piperidinyl Cyclopentyl Aryl Benzylamide Modulators of Chemokine Receptor Activity
Mitotic Kinesin Inhibitors
Mitotic Kinesin Inhibitors
Substituted Pyrazolo[1,5-a]Pyrimidines as Tyrosine Kinase Inhibitors
Substituted Pyrazoles, Compositions Containing Such Compounds and Methods of Use
Aminocyclopentyl Fused Heterotricylicamide Modulators of Chemokine Receptor Activity
Process for the Preparation of Chiral Beta Amino Acid Derivatives by Asymmetric Hydrogenation
Amino Cyclobutylamide Modulators of Chemokine Receptor Activity
Benzamide Modulators of Metabotropic Glutamate Receptors
Synthesis of Functional Polymers for Use in Organic Synthesis and Combinatorial Chemistry
Biaryl Substituted Pyrazoles as Sodium Channel Blockers
Polymorphic Form of Montelukast Sodium
Inhibitors of Akt Activity
Benzamidazoles, Compositions Containing Such Compounds and Methods of Use
3-Amino-4-Phenylbutanoic Acid Derivatives as Dipeptidyl Peptidase Inhibitors for the Treatment or Prevention of Diabetes
17-Acetamido-4-Azasteroid Derivatives as Androgen Receptor Modulators
Substituted 3-Alkyl and 3-Alkenyl Azetidine Derivatives
3-Fluoro-Piperidines as Nmda/NR2B Antagonists
Cyclohexylglycine Derivatives as Dipeptidyl Peptidase Inhibitors for the Treatment or Prevention of Diabetes
Benzodiazepine Cgrp Receptor Antagonists
Tyrosine Kinase Inhibitors
Diphenyl Substituted Cycloalkanes, Compositions Containing Such Compounds and Methods of Use
Tetrahydropyran Heterocyclic Cyclopentyl Heteroaryl Modulators of Chemokine Receptor Activity
Ophthalmic Compositions for Treating Ocular Hypertension
Ophthalmic Compositions for Treating Ocular Hypertension
Phenyl Pyrrolidine Ether Tachykinin Receptor Antagonists
(3,4-Disubstituted)Propanoic Carboxylates as S1P (Edg) Receptor Agonists
Ccr-2 Antagonist Salt
Optimized Expression of Hpv 58 L1 in Yeast
Cynomolgus Monkey Dickkopf-4, Nucleotides Encoding Same, and Uses Thereof
Rhesus Monkey Dickkopf-1, Nucleotides Encoding Same, and Uses Thereof
Mitotic Kinesin Inhibitors
Phenylamide and Pyridylamide Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
Cgrp Receptor Antagonists
Hiv Integrase Inhibitors
Vla-4 Antagonists
Hiv Integrase Inhibitors
Mitotic Kinesin Inhibitors
Cyclopropyl Group Substituted Oxazolidinone Antibiotics and Derivatives Thereof
Fluorinated 2,4-diaryl-2,5-dihydropyrrole Inhibitors of the Mitotic kinesin KSP
Substituted Triazoles as Sodium Channel Blockers
Triazole Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase-1
Adenovirus Formulations
Pyridazine, Pyrimidine and Pyrazine Ethyne Compounds
Asymmetric Hydrogenation Process
Pyrazole Derivatives, Compositions Containing Such Compounds and Methods of Use
Anti-Hypercholesterolemic Compounds
Potassium Channel Inhibitors
Substituted Imidazoles as Cannabinoid Receptor Modulators
Cyanation of Aromatic Halides
2-Aryloxy-2-Arylalkanoic Acids for Diabetes and Lipid Disorders
Rhesus Monkey NUR77
Compressed Tablet Formulation
Tyrosine Kinase Inhibitors
Process for Making Hydroisoindoline Tachykinin Receptor Antagonists
Hcv NS3 Protease Inhibitors
4-Azasteroid Derivatives as Androgen Receptor Modulators
Beta-Secretase Substrates and Uses Thereof
Process for the Preparation of Enantiomerically Enriched Beta Amino Acid Derivatives
Process for Making N-Sulfonated-Amino Acid Derivatives
Morpholinyl Piperidine Glycine Transporter Inhibitors
Hiv Integrase Inhibitors
Acyl Indoles, Compositions Containing Such Compounds and Methods of Use
Tetrahydropyranyl Cyclopentyl Tetrahydropyridopyridine Modulators of Chemokine Receptor Activity
3,3-Disubstituted Tetrahydropyranyl Cyclopentyl Amide Modulators of Chemokine Receptor Activity
Spirocyclic Compounds
P38 Kinase Inhibiting Agents
C-Purine Nucleoside Analogs as Inhibitors of Rna-Dependent Rna Viral Polymerase
N-(2-Benzyl)-2-Phenylbutanamides as Androgen Receptor Modulators
Aminocyclohexanes as Dipeptidyl Peptidase-Iv Inhibitors for the Treatment or Prevention of Diabetes
Formation of Tetra-Substituted Enamides and Stereoselective Reduction Thereof
Hiv Integrase Inhibitors
Histone Deacetylase Inhibitors
Histone Deacetylase Inhibitors
Ophthalmic Compositions for Treating Ocular Hypertension
Mitotic Kinesin Inhibitors
Mitotic Kinesin Inhibitors
Indoles Having Anti-Diabetic Activity
Acylated Piperidine Derivatives as Melanocortin 4-Receptor Agonists
Substituted Pyrazoles, Compositions Containing Such Compounds and Methods of Use
Ophthalmic Compositions for Treating Ocular Hypertension
Canis Sphingosine 1-Phosphate Receptor Isoform 1
Inhibitors of Akt Activity
Fused Triazole Derivatives as Dipeptidyl Peptidase-Iv Inhibitors for the Treatment or Prevention of Diabetes
Androgen Receptor Modulators
Amorphous Form of a Phosphoric Acid Salt of a Dipeptidyl Peptidase-Iv Inhibitor
Compounds for the Treatment of Dyslipidemia and Other Lipid Disorders
Assay for Cytochrome P450 Isoform 2C9
Substituted Pyrazine Inhibitors of Akt
Inhibitors of Checkpoint Kinases
Estrogen Receptor Modulators
Inhibitors of Checkpoint Kinases
Inhibitors of Akt Activity
Substituted Monocyclic Cgrp Receptor Antagonists
Optimized Expression of Hpv 45 L1 in Yeast
Optimized Expression of Hpv 31 L1 in Yeast
Mitotic Kinesin Inhibitors
Mitotic Kinesin Inhibitors
Mitotic Kinesin Inhibitors
1H-Benzo[F]Indazol-5-Yl Derivatives as Selective Glucocorticoid Receptor Modulators
Inhibitors of Akt Activity
Crystalline Forms of Carbapenem Antibiotics and Methods of Preparation
Patent:
40,794 →
Application:
11/999,720 →
Hcv Rna-Dependent Rna Polymerase
Substituted Amides
Biaryl Substituted Triazoles as Sodium Channel Blockers
Substituted Pyridyoxy Amides
Process for Making Spirolactone Compounds
Cgrp Receptor Antagonists
Inhibitors of Checkpoint Kinases
Substituted Monocyclic Cgrp Receptor Antagonists
Fluorinated 4-Azasteroid Derivatives as Androgen Receptor Modulators
Inhibitors of Akt Activity
Application:
12/482,095 →
Publication:
US 2009/0253734
Tablet
Patent:
375,157 →
Application:
29/002,841 →
Pharmaceutical Tablet
Patent:
380,825 →
Application:
29/030,494 →
Pharmaceutical Tablet
Patent:
379,223 →
Application:
29/043,867 →
Pharmaceutical Tablet
Patent:
400,672 →
Application:
29/052,038 →
Combined Dispenser and Cap
Patent:
405,005 →
Application:
29/080,877 →
Tablet
Patent:
425,614 →
Application:
29/103,611 →
Tablet
Patent:
434,846 →
Application:
29/108,430 →
Tablet
Patent:
431,076 →
Application:
29/108,431 →
Pharmaceutical Kit
Patent:
457,246 →
Application:
29/115,771 →
Pharmaceutical Kit
Patent:
480,958 →
Application:
29/164,695 →
Tablet
Patent:
515,202 →
Application:
29/209,646 →
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Merger
Aug 27, 2012
From: MERCK SHARP & DOHME CORP.
To: SCHERING CORPORATION
Reel/Frame 028850/0515 →
Change of Name
Aug 29, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028866/0511 →
Assignment of Assignor's Interest
Apr 21, 2014
From: ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A.
To: MSD ITALIA S.R.L.
Reel/Frame 032720/0243 →
Merger
Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →